n-(Benzoyl)-3-methyl-n'-[(4,7-dimethoxy-6-azaindol-3-yl)-oxoacetyl]piperazine → 4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridine
Reaktionsgleichung
C(N1CCN(C(=O)C([C:18]2[C:26]3[C:21](=[C:22]([O:29][CH3:30])[N:23]=[CH:24][C:25]=3[O:27][CH3:28])[NH:20][CH:19]=2)=O)C(C)C1)(=O)C1C=CC=CC=1.COC1C=NC(OC)=C2C=1C(C(=O)C([O-])=O)=CN2.[K+]>>[CH3:28][O:27][C:25]1[CH:24]=[N:23][C:22]([O:29][CH3:30])=[C:21]2[C:26]=1[CH:18]=[CH:19][NH:20]2Komponenten
3
Versuchsvorschrift
Compound 5ap, {circle around (R)}N-(benzoyl)-3-methyl-N′-[(4,7-dimethoxy-6-azaindol-3-yl)-oxoacetyl]piperazine (white solid) was prepared using the same method used to prepare compound 5a except that Potassium (4,7-dimethoxy-6-azaindol-3-yl)-oxoacetate was used as the starting material. MS m/z: (M+H)+ calcd for C23H25N4O5: 437.18; found 437.24. HPLC retention time: 1.37 minutes (column B).
Quellen und Nachweise
- ORD-Eintrag
- ord-7ce9117157144bd7b0b8a0126c95a21e